H.C. Wainwright Starts Biodesix (BDSX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq falls as Alphabet set for record loss amid AI spending woes
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts BDSX Hot Sheet
Price: $24.54 +7.35%
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 24 | New: 16
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 24 | New: 16
Join SI Premium – FREE
H.C. Wainwright analyst Yi Chen initiates coverage on Biodesix (NASDAQ: BDSX) with a Buy rating and a price target of $26.00.
For an analyst ratings summary and ratings history on Biodesix click here. For more ratings news on Biodesix click here.
Shares of Biodesix closed at $15.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Establishment Labs Inc. (ESTA) PT Lowered to $93 at BTIG
- Griffin Securities Downgrades Microsoft (MSFT) to Neutral
- Biogen (BIIB) PT Raised to $275 at Freedom Broker
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, H.C. Wainwright, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
